DE60309344D1 - Derivate von ä6, 7-dihydro -5h-imidazoä1,2 - aüimidazol -3 -sulfonylaminoü-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen - Google Patents

Derivate von ä6, 7-dihydro -5h-imidazoä1,2 - aüimidazol -3 -sulfonylaminoü-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen

Info

Publication number: DE60309344D1
Authority: DE; Germany
Prior art keywords: sulfonylaminoü; leukoin; imidazoä1; aimidazole; propionamide
Prior art date: 2002-10-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60309344T

Other languages

English (en)

Other versions

DE60309344T2 (de

Inventor

Terence Alfred Kelly

Jin Mi Kim

Rene Marc Lemieux

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharmaceuticals Inc

Original Assignee

Boehringer Ingelheim Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-30

Filing date

2003-10-27

Publication date

2006-12-07

2003-10-27 Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc

2006-12-07 Application granted granted Critical

2006-12-07 Publication of DE60309344D1 publication Critical patent/DE60309344D1/de

2007-02-08 Publication of DE60309344T2 publication Critical patent/DE60309344T2/de

2023-10-28 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Immunology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DE60309344T 2002-10-30 2003-10-27 Derivate von ä6, 7-dihydro -5h-imidazoä1,2 - aüimidazol -3 -sulfonylaminoü-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen Expired - Fee Related DE60309344T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42244602P	2002-10-30	2002-10-30
US422446P		2002-10-30
PCT/US2003/033865 WO2004041827A2 (en)	2002-10-30	2003-10-27	DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-α] IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE AND THEIR USE AS INHIBITORS UPON THE INTERACTION OF CAMS AND LEUKO INTEGRINS

Publications (2)

Publication Number	Publication Date
DE60309344D1 true DE60309344D1 (de)	2006-12-07
DE60309344T2 DE60309344T2 (de)	2007-02-08

Family

ID=32312506

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60309344T Expired - Fee Related DE60309344T2 (de)	2002-10-30	2003-10-27	Derivate von ä6, 7-dihydro -5h-imidazoä1,2 - aüimidazol -3 -sulfonylaminoü-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen

Country Status (32)

Country	Link
US (4)	US6844360B2 (de)
EP (1)	EP1560830B1 (de)
JP (1)	JP4366477B2 (de)
KR (1)	KR20050067426A (de)
CN (1)	CN1708500A (de)
AR (1)	AR041854A1 (de)
AT (1)	ATE343582T1 (de)
AU (1)	AU2003284938A1 (de)
BR (1)	BR0315836A (de)
CA (1)	CA2504219A1 (de)
CO (1)	CO5690604A2 (de)
CY (1)	CY1106258T1 (de)
DE (1)	DE60309344T2 (de)
DK (1)	DK1560830T3 (de)
EA (1)	EA008443B1 (de)
EC (1)	ECSP055823A (de)
ES (1)	ES2276134T3 (de)
HR (1)	HRP20050387A2 (de)
MX (1)	MXPA05004480A (de)
MY (1)	MY136822A (de)
NO (1)	NO20052579L (de)
NZ (1)	NZ540269A (de)
PE (1)	PE20040782A1 (de)
PL (1)	PL375709A1 (de)
PT (1)	PT1560830E (de)
RS (1)	RS20050327A (de)
SI (1)	SI1560830T1 (de)
TW (1)	TW200424204A (de)
UA (1)	UA80160C2 (de)
UY (1)	UY28049A1 (de)
WO (1)	WO2004041827A2 (de)
ZA (1)	ZA200502701B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6492408B1 (en) *	1999-07-21	2002-12-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
US6852748B1 (en) *	2002-10-30	2005-02-08	Boehringer Ingelheim Pharmaceuticals, Inc.	Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
US6844360B2 (en) *	2002-10-30	2005-01-18	Boehringer Ingelheim Pharmaceuticals, Inc.	Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
EP1712553A3 (de) *	2002-10-30	2006-11-02	Boehringer Ingelheim Pharmaceuticals, Inc.	Derivate von [6,7-dihydro-5h-imidazo[1,2-alpha]imidazol-3-sulfonylamino]-Propionamid und deren Verwendung als Inhibitoren der Interaktion von CAMS und Leukointegrinen
US8699508B2 (en) *	2003-12-18	2014-04-15	Intel Corporation	Response scheduling for multiple receivers
KR20070047798A (ko) *	2004-07-27	2007-05-07	베링거 인겔하임 인터내셔날 게엠베하	6,7-디하이드로-5Ｈ-이미다조[1,2-ａ]이미다졸-3-설폰산아미드의 합성
WO2006107941A1 (en) *	2005-04-06	2006-10-12	Boehringer Ingelheim International Gmbh	DERIVATIVES OF [6,7-DIHYDRO-5HIMIDAZO [l,2-ALPHA] IMIDAZOLE-3-SULFONYL]-AZETEDINE-CARBOXYLIC ACIDS, ESTERS AND AMIDES AND USE THEREOF AS ANTI-INFLAMMATORY AGENTS
CN101166743A (zh) *	2005-05-19	2008-04-23	贝林格尔·英格海姆国际有限公司	6,7-二氢-5H-咪唑并[1,2-α]咪唑-3-磺酸的衍生物
WO2007084882A2 (en) *	2006-01-20	2007-07-26	Boehringer Ingelheim International Gmbh	Process for the preparation of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides and intermediates used therein
RS53602B1 (sr) *	2007-11-29	2015-02-27	Boehringer Ingelheim International Gmbh	DERIVATI AMIDA 6,7-DIHIDRO-5H-IMIDAZO[1,2-α]IMIDAZOL-3-KARBOKSILNE KISELINE
JP5384732B2 (ja) *	2009-06-02	2014-01-08	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	６，７−ジヒドロ−５Ｈ−イミダゾ［１，２−ａ］イミダゾール−３−カルボン酸アミドの誘導体
WO2010141330A1 (en)	2009-06-02	2010-12-09	Boehringer Ingelheim International Gmbh	DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
WO2021217040A1 (en) *	2020-04-24	2021-10-28	Immvention Therapeutix	Carbamate and urea derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EE9900481A (et)	1997-03-03	2000-06-15	Boehringer Ingelheim Pharmaceuticals, Inc.	Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
US6355664B1 (en)	1997-03-03	2002-03-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
US6492408B1 (en)	1999-07-21	2002-12-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Small molecules useful in the treatment of inflammatory disease
US6414161B1 (en) *	2000-08-09	2002-07-02	Boehringer Ingelheim Pharmaceuticals, Inc.	Synthesis of (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one
US6844360B2 (en)	2002-10-30	2005-01-18	Boehringer Ingelheim Pharmaceuticals, Inc.	Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
US6852748B1 (en) *	2002-10-30	2005-02-08	Boehringer Ingelheim Pharmaceuticals, Inc.	Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide

2003
- 2003-10-15 US US10/686,073 patent/US6844360B2/en not_active Expired - Lifetime
- 2003-10-27 RS YUP-2005/0327A patent/RS20050327A/sr unknown
- 2003-10-27 ES ES03779257T patent/ES2276134T3/es not_active Expired - Lifetime
- 2003-10-27 NZ NZ540269A patent/NZ540269A/en unknown
- 2003-10-27 MX MXPA05004480A patent/MXPA05004480A/es active IP Right Grant
- 2003-10-27 DK DK03779257T patent/DK1560830T3/da active
- 2003-10-27 BR BR0315836-5A patent/BR0315836A/pt not_active IP Right Cessation
- 2003-10-27 HR HR20050387A patent/HRP20050387A2/xx not_active Application Discontinuation
- 2003-10-27 DE DE60309344T patent/DE60309344T2/de not_active Expired - Fee Related
- 2003-10-27 PL PL03375709A patent/PL375709A1/xx not_active Application Discontinuation
- 2003-10-27 EA EA200500603A patent/EA008443B1/ru not_active IP Right Cessation
- 2003-10-27 JP JP2004550109A patent/JP4366477B2/ja not_active Expired - Fee Related
- 2003-10-27 WO PCT/US2003/033865 patent/WO2004041827A2/en not_active Ceased
- 2003-10-27 CA CA002504219A patent/CA2504219A1/en not_active Abandoned
- 2003-10-27 SI SI200330574T patent/SI1560830T1/sl unknown
- 2003-10-27 CN CNA2003801024910A patent/CN1708500A/zh active Pending
- 2003-10-27 AT AT03779257T patent/ATE343582T1/de not_active IP Right Cessation
- 2003-10-27 PT PT03779257T patent/PT1560830E/pt unknown
- 2003-10-27 KR KR1020057007452A patent/KR20050067426A/ko not_active Withdrawn
- 2003-10-27 AU AU2003284938A patent/AU2003284938A1/en not_active Abandoned
- 2003-10-27 UA UAA200505014A patent/UA80160C2/uk unknown
- 2003-10-27 EP EP03779257A patent/EP1560830B1/de not_active Expired - Lifetime
- 2003-10-28 TW TW092129932A patent/TW200424204A/zh unknown
- 2003-10-28 MY MYPI20034095A patent/MY136822A/en unknown
- 2003-10-28 PE PE2003001088A patent/PE20040782A1/es not_active Application Discontinuation
- 2003-10-28 UY UY28049A patent/UY28049A1/es not_active Application Discontinuation
- 2003-10-29 AR ARP030103945A patent/AR041854A1/es unknown
2004
- 2004-10-20 US US10/969,105 patent/US7345074B2/en not_active Expired - Lifetime
2005
- 2005-01-13 US US11/034,701 patent/US7304067B2/en not_active Expired - Lifetime
- 2005-04-04 ZA ZA200502701A patent/ZA200502701B/en unknown
- 2005-05-26 CO CO05051551A patent/CO5690604A2/es not_active Application Discontinuation
- 2005-05-27 NO NO20052579A patent/NO20052579L/no not_active Application Discontinuation
- 2005-05-30 EC EC2005005823A patent/ECSP055823A/es unknown
2006
- 2006-11-09 CY CY20061101615T patent/CY1106258T1/el unknown
2007
- 2007-10-15 US US11/872,276 patent/US7589115B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
UA80160C2 (en)	2007-08-27
EA008443B1 (ru)	2007-06-29
US6844360B2 (en)	2005-01-18
DE60309344T2 (de)	2007-02-08
MY136822A (en)	2008-11-28
US7304067B2 (en)	2007-12-04
MXPA05004480A (es)	2005-07-26
KR20050067426A (ko)	2005-07-01
ES2276134T3 (es)	2007-06-16
NO20052579L (no)	2005-05-27
AU2003284938A1 (en)	2004-06-07
BR0315836A (pt)	2005-09-13
WO2004041827A2 (en)	2004-05-21
PT1560830E (pt)	2007-01-31
PL375709A1 (en)	2005-12-12
CO5690604A2 (es)	2006-10-31
US7345074B2 (en)	2008-03-18
US20080090819A1 (en)	2008-04-17
AR041854A1 (es)	2005-06-01
UY28049A1 (es)	2004-05-31
ZA200502701B (en)	2005-10-13
ECSP055823A (es)	2005-08-11
PE20040782A1 (es)	2004-12-16
SI1560830T1 (sl)	2007-02-28
EA200500603A1 (ru)	2005-10-27
EP1560830B1 (de)	2006-10-25
US7589115B2 (en)	2009-09-15
HRP20050387A2 (en)	2006-10-31
ATE343582T1 (de)	2006-11-15
WO2004041827A3 (en)	2004-07-15
JP2006508947A (ja)	2006-03-16
US20050165027A1 (en)	2005-07-28
CY1106258T1 (el)	2011-06-08
NZ540269A (en)	2007-05-31
DK1560830T3 (da)	2007-02-26
JP4366477B2 (ja)	2009-11-18
US20050054703A1 (en)	2005-03-10
EP1560830A2 (de)	2005-08-10
TW200424204A (en)	2004-11-16
RS20050327A (sr)	2007-06-04
CA2504219A1 (en)	2004-05-21
US20040127534A1 (en)	2004-07-01
CN1708500A (zh)	2005-12-14

Publication	Publication Date	Title
DE60325761D1 (de)	2009-02-26	Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
ATE367381T1 (de)	2007-08-15	Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren
DE60328087D1 (de)	2009-08-06	Aryl substituierte pyrimidine und deren verwendung
DE60329318D1 (de)	2009-10-29	4-oxochinolinverbindungen und deren verwendung als hiv-integrase-inhibitoren
DE602004021037D1 (de)	2009-06-18	Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
DE60321043D1 (de)	2008-06-26	Biphenylderivate und deren verwendung als fungizide
DE602004028934D1 (de)	2010-10-14	Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
DE60315892D1 (de)	2007-10-04	Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung
DE60314600D1 (de)	2007-08-09	O-cyclopropyl-carboxanilide und ihre verwendung als fungizide
ATE371658T1 (de)	2007-09-15	Purinderivate und ihre verwendung als liganden des cannabinoid rezeptors
ATE346056T1 (de)	2006-12-15	Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
DE60308998D1 (de)	2006-11-23	N-aryl-2-oxazolidinon-5-carbonsäureamide und deren derivate und deren verwendung als antibakterielle mittel
DE60308387D1 (de)	2006-10-26	Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
ATE512965T1 (de)	2011-07-15	Pyrrolopyrimidin derivate
DE60321722D1 (de)	2008-07-31	Derivate von aryl-chinazolin/aryl-2amino-phenyl-methanon zurförderung der freisetzung von parathormon
EP1469860A4 (de)	2005-09-07	Antikrebskombination und deren verwendung
EP1499186A4 (de)	2009-10-28	Verwendung von häm-oxygenase-1 und häm-abbauprodukte
DE60309344D1 (de)	2006-12-07	Derivate von ä6, 7-dihydro -5h-imidazoä1,2 - aüimidazol -3 -sulfonylaminoü-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen
ATE551329T1 (de)	2012-04-15	Chinazolinonderivate und deren verwendung als cb- agonisten
DE60336720D1 (de)	2011-05-26	Fluorsulfate von hexafluorisobutylen und dessen höheren homologen und deren derivaten
ATE353083T1 (de)	2007-02-15	Naphthyridin-derivate und ihre verwendung als fungizide
ATE499096T1 (de)	2011-03-15	Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
DE60311277D1 (de)	2007-03-08	Benzotriazabicyclische derivate und deren verwendung als beta-lactamaseinhibitoren und antibakterielle mittel
ATE413387T1 (de)	2008-11-15	Substituierte pyridyloxyalkylamide und ihre verwendung als fungizide
ATE369371T1 (de)	2007-08-15	1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung

Legal Events

Date	Code	Title	Description
2007-11-15	8364	No opposition during term of opposition
2010-08-19	8339	Ceased/non-payment of the annual fee